Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-07

Clinical Trial Update: Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing bilastine and loratadine in allergic rhinitis evaluated quality of life outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bilastine (bilastine)
  • Loratadine (Loratadine)

Snippet

Sponsor: Universidade do Sul de Santa Catarina | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED